End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
5.87
CNY
|
+1.91%
|
|
+4.45%
|
-10.65%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,499
|
2,565
|
2,902
|
3,962
|
3,445
|
3,671
|
Enterprise Value (EV)
1 |
1,530
|
2,502
|
2,652
|
3,836
|
3,373
|
3,061
|
P/E ratio
|
28.9
x
|
25.4
x
|
10
x
|
13.3
x
|
9.78
x
|
13.2
x
|
Yield
|
-
|
-
|
0.49%
|
-
|
-
|
3.04%
|
Capitalization / Revenue
|
0.92
x
|
1.19
x
|
1.43
x
|
1.47
x
|
1.1
x
|
1.55
x
|
EV / Revenue
|
0.94
x
|
1.16
x
|
1.31
x
|
1.42
x
|
1.08
x
|
1.29
x
|
EV / EBITDA
|
5.12
x
|
6.95
x
|
6.43
x
|
10.1
x
|
6.6
x
|
10.1
x
|
EV / FCF
|
809
x
|
54.9
x
|
19.5
x
|
-41.7
x
|
-19.3
x
|
-33.2
x
|
FCF Yield
|
0.12%
|
1.82%
|
5.13%
|
-2.4%
|
-5.19%
|
-3.01%
|
Price to Book
|
1.4
x
|
2.19
x
|
1.98
x
|
2.32
x
|
1.68
x
|
1.22
x
|
Nbr of stocks (in thousands)
|
461,790
|
461,790
|
461,790
|
461,790
|
461,790
|
558,742
|
Reference price
2 |
3.246
|
5.554
|
6.285
|
8.580
|
7.460
|
6.570
|
Announcement Date
|
3/25/19
|
4/6/20
|
3/22/21
|
4/6/22
|
4/24/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,628
|
2,152
|
2,026
|
2,702
|
3,130
|
2,374
|
EBITDA
1 |
298.8
|
360.2
|
412.2
|
378
|
511.4
|
302
|
EBIT
1 |
244
|
304.7
|
364.2
|
317.7
|
428.4
|
210
|
Operating Margin
|
14.99%
|
14.16%
|
17.97%
|
11.76%
|
13.69%
|
8.84%
|
Earnings before Tax (EBT)
1 |
167.7
|
169.9
|
365
|
330.3
|
434.6
|
304.6
|
Net income
1 |
51.5
|
101.1
|
289.1
|
268.4
|
352.3
|
273.8
|
Net margin
|
3.16%
|
4.7%
|
14.27%
|
9.93%
|
11.25%
|
11.53%
|
EPS
2 |
0.1122
|
0.2189
|
0.6261
|
0.6431
|
0.7628
|
0.4972
|
Free Cash Flow
1 |
1.891
|
45.59
|
136
|
-91.98
|
-174.9
|
-92.2
|
FCF margin
|
0.12%
|
2.12%
|
6.71%
|
-3.4%
|
-5.59%
|
-3.88%
|
FCF Conversion (EBITDA)
|
0.63%
|
12.66%
|
33%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
3.67%
|
45.1%
|
47.05%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
0.0308
|
-
|
-
|
0.2000
|
Announcement Date
|
3/25/19
|
4/6/20
|
3/22/21
|
4/6/22
|
4/24/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
30.6
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
62.3
|
250
|
126
|
71.5
|
610
|
Leverage (Debt/EBITDA)
|
0.1024
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1.89
|
45.6
|
136
|
-92
|
-175
|
-92.2
|
ROE (net income / shareholders' equity)
|
13.4%
|
10.2%
|
21.8%
|
16.3%
|
18.6%
|
10.6%
|
ROA (Net income/ Total Assets)
|
7.39%
|
8.18%
|
8.46%
|
6.17%
|
7.41%
|
3.15%
|
Assets
1 |
697.3
|
1,236
|
3,418
|
4,352
|
4,756
|
8,687
|
Book Value Per Share
2 |
2.320
|
2.540
|
3.170
|
3.700
|
4.430
|
5.380
|
Cash Flow per Share
2 |
0.9800
|
1.090
|
1.730
|
1.020
|
1.670
|
1.900
|
Capex
1 |
87.1
|
98.2
|
263
|
185
|
321
|
383
|
Capex / Sales
|
5.35%
|
4.56%
|
12.98%
|
6.83%
|
10.26%
|
16.14%
|
Announcement Date
|
3/25/19
|
4/6/20
|
3/22/21
|
4/6/22
|
4/24/23
|
4/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -10.65% | 453M | | +2.36% | 3.63B | | -17.31% | 2.23B | | -9.80% | 1.92B | | +3.66% | 1.88B | | -1.86% | 1.67B | | +2.91% | 1.17B | | -22.39% | 1.03B | | -4.02% | 993M | | +2.36% | 822M |
Pesticide
|